CompoAtlas

Lypsyl Extreme Cold Sore Relief

Natural health product licensed in Canada

Other names
Extreme Cold Sore Relief
Licence holder
LPNA Group, Inc. d/b/a Lornamead Products
NPN or DIN-HM
80074319
Status
Active licence
Licence date
9 December 2016
Revision date
14 May 2021
Form
Crème
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
l-Menthol

Source : Mentha X piperita - feuille

0.7 %
D-camphre

Source : d-Camphre

0.45 %

Non-medicinal ingredients

Beurre de Butyrospermum Parkii (Karité), Acétate de dl-alpha tocophéryle, Dioxyde de titane, Cire d'abeille, 2-Methyl-1-propene, homopolymer, Extrait de feuille d'eucalyptus globulus, Ethylene/Propylene/styrene copolymer, Extrait de cire de propolis, Essence de feuilles Melaleuca alternifolia, Allantoïne, Lactate de zinc, (p)-hydroxybenzoate de propyle, Tétracaprylate/Tétracaprate de pentaérythrityle, Bisabolol, Hydrogenated Polyisobutene, Butylene/ethylene/styrene Copolymer, Pétrolatum, Palmitate d'ascorbyle, extrait de fleur de Lavendula angustifolia (lavande), Diméthicone, Lysine, Chamomilla Recutita (Matricaria) Flower Extract, Extrait de feuilles d'Aloe barbadensis, Extrait de graine d'Helianthus Annus (tournesol)

PopulationAgeQuantity per servingFrequency
Adultes et enfantsNot specifiedNot specifiedminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

For the temporary relief of pain & itching associated with cold sores and fever blisters.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80074319

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line